Relapsed diffuse large B-cell lymphoma (DLBCL) involving the central nervous system (CNS) remains a major therapeutic challenge for hemato-oncologists. Rituximab-based front-line regimens such as C...
No takes yet. Share an insight, caveat, or question.
Weyden et al. (2015) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: